Cardiovascular disease (CVD) remains the leading cause of mortality in women, yet many
people perceive breast cancer to be the number one threat to women's health. CVD and …

Cardiovascular disease is a competing cause of death in patients with cancer with early-
stage disease. This elevated cardiovascular disease risk is thought to derive from both the …

Cardio-oncology is an emerging discipline focused predominantly on the detection and
management of cancer treatment–induced cardiac dysfunction (cardiotoxicity), which …

Background: Breast cancer survivors treated with anthracycline-based chemotherapy (AC)
have increased risk of functional limitation and cardiac dysfunction. We conducted a 12 …

The NCCN Guidelines for Survivorship provide screening, evaluation, and treatment
recommendations for common physical and psychosocial consequences of cancer and …

Background Muscle dysfunction is a prevalent phenomenon in the oncology setting where
patients across a wide range of diagnoses are subject to impaired muscle function …

Purpose Cardiovascular disease (CVD) is a leading cause of death among women with
nonmetastatic breast cancer. Whether exercise is associated with reductions in CVD risk in …

There are nearly 17 million cancer survivors in the United States, including those who are
currently receiving cancer therapy with curative intent and expected to be long-term …

The US population of cancer survivors age≥ 65 years will continue to grow rapidly over the
next few decades. This growth will be driven largely by the aging of the national population …

Pre-operative exercise therapy improves outcomes for many patients who undergo surgery.
Despite the well-known effects on tolerance to systemic perturbation, the mechanisms by …